Wells Fargo Maintains Overweight on Westlake, Lowers Price Target to $105
Wells Fargo analyst Michael Sison maintains Westlake (NYSE:WLK) with a Overweight and lowers the price target from $112 to $105.
Westlake Chemical Q3 EPS $3.10 Misses $4.30 Estimate, Sales $4.00B Beat $3.99B Estimate
Westlake Chemical (NYSE:WLK) reported quarterly earnings of $3.10 per share which missed the analyst consensus estimate of $4.30 by 27.91 percent. This is a 33.9 percent decrease over earnings of $4.69 per share from the
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell
• Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
Deutsche Bank Downgrades Westlake to Hold, Announces $95 Price Target
Deutsche Bank analyst David Begleiter downgrades Westlake (NYSE:WLK) from Buy to Hold and announces $95 price target.
Westlake Set To Join S&P MidCap 400, Replacing MillerKnoll; MillerKnoll To Replace Covetrus In S&P SmallCap 600
Westlake Corp. (NYSE:WLK) will replace MillerKnoll Inc. (NASD:MLKN) in the S&P MidCap 400, and MillerKnoll will replace Covetrus Inc. (NASD:CVET) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, October 18.
Goldman Sachs Initiates Coverage On Westlake with Neutral Rating, Announces Price Target of $93
Goldman Sachs analyst Duffy Fischer initiates coverage on Westlake (NYSE:WLK) with a Neutral rating and announces Price Target of $93.
Piper Sandler Maintains Neutral on Westlake, Lowers Price Target to $110
Piper Sandler analyst Charles Neivert maintains Westlake (NYSE:WLK) with a Neutral and lowers the price target from $115 to $110.
UBS Upgrades Westlake to Neutral, Raises Price Target to $95
UBS analyst Joshua Spector upgrades Westlake (NYSE:WLK) from Sell to Neutral and raises the price target from $92 to $95.
